×
Avantor Receivables 2018-2025 | AVTR
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Avantor receivables for the quarter ending June 30, 2025 were
$1.149B
, a
1.81% increase
year-over-year.
Avantor receivables for 2024 were
$1.035B
, a
10.06% decline
from 2023.
Avantor receivables for 2023 were
$1.15B
, a
5.6% decline
from 2022.
Avantor receivables for 2022 were
$1.218B
, a
0.3% decline
from 2021.
View More
Avantor Receivables 2018-2025 | AVTR
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Avantor receivables for 2024 were
$1.035B
, a
10.06% decline
from 2023.
Avantor receivables for 2023 were
$1.15B
, a
5.6% decline
from 2022.
Avantor receivables for 2022 were
$1.218B
, a
0.3% decline
from 2021.
Related Stocks
Company Name
Market
Cap
Danaher (DHR)
$151.7B
CVS Health (CVS)
$90.4B
Elevance Health (ELV)
$71.3B
Cencora (COR)
$56.7B
DiDi Global (DIDIY)
$27.6B
Labcorp Holdings (LH)
$23.1B
Natera (NTRA)
$22.7B
BioMerieux (BMXMF)
$17.5B
EUROFINS SCIENT (ERFSF)
$15.7B
ICON (ICLR)
$14.2B
Medpace Holdings (MEDP)
$13B
CochLear (CHEOY)
$12.8B
Solventum (SOLV)
$12.8B
Viatris (VTRS)
$12.4B
Caris Life Sciences,�Inc (CAI)
$11.1B
Revvity (RVTY)
$10.9B
Sonic Healthcare (SKHHY)
$8B
Charles River Laboratories (CRL)
$8B
HealthEquity (HQY)
$7.8B
Bausch + Lomb (BLCO)
$5.3B
Sotera Health (SHC)
$4.7B
BrightSpring Health Services (BTSG)
$4.4B
Amplifon S.p.A (AMFPF)
$3.9B
KindlyMD (NAKA)
$3.8B
GeneDx Holdings (WGS)
$3.7B
Alignment Healthcare (ALHC)
$3.1B
Concentras Parent (CON)
$3B
Surgery Partners (SGRY)
$3B
Organon (OGN)
$2.5B
Premier (PINC)
$2.1B